HighPoint Advisor »

Tenaya Therapeutics shares owned by HighPoint Advisor

Quarter-by-quarter ownership of Tenaya Therapeutics (TNYA) shares owned by HighPoint Advisor from 13F filings

Historical chart of HighPoint Advisor investment in Tenaya Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tenaya Therapeutics held by HighPoint Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tenaya Therapeutics by HighPoint Advisor

Quarter filed Position value Share count Share price at filing
2023-12-31 $342k 70k 4.86

More positions owned by HighPoint Advisor

Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Jpmorgan Chase & Co Common Stock (JPM)
Abbvie Common Stock (ABBV)
Meta Platforms Inc Cl A Common Stock (META)
Alphabet Inc Cl A Common Stock (GOOGL)
Exxon Mobil Corp Common Stock (XOM)
Berkshire Hathaway Inc Cl B Common Stock (BRK.B)
Alphabet Inc Cl C Common Stock (GOOG)
Procter & Gamble Common Stock (PG)
Coca-cola Consolidated Common Stock (COKE)
Cme Group Inc Cl A Common Stock (CME)
Tesla Common Stock (TSLA)

View all positions for HighPoint Advisor

Top funds holding Tenaya Therapeutics

Column Group
Casdin Capital
RA Capital Management
T. Rowe Price Associates
Vanguard Group
Citadel Advisors
Euclidean Capital
Alphabet
Millennium Management
GSA Capital Partners
TD Asset Management
Bank of New York Mellon
Two Sigma Investments
Bank of America Corporation
Squarepoint Ops

View all funds holding Tenaya Therapeutics